Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
Tongzheng Liu, Jia Yu, Min Deng, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz, Masakazu Toi, Mario Campone, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 32, pp. 3638-3646
Closed Access | Times Cited: 1423
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
Shom Goel, Molly J. DeCristo, Sandra S. McAllister, et al.
Trends in Cell Biology (2018) Vol. 28, Iss. 11, pp. 911-925
Open Access | Times Cited: 387
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao, Chunyan Gu, Ye Gan, et al.
Journal of Controlled Release (2019) Vol. 318, pp. 1-15
Closed Access | Times Cited: 321
Targeting CDK4 and CDK6 in cancer
Shom Goel, Johann S. Bergholz, Jean J. Zhao
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 356-372
Open Access | Times Cited: 321
CDK4/6 inhibition in breast cancer: current practice and future directions
Sònia Pernas, Sara M. Tolaney, Eric P. Winer, et al.
Therapeutic Advances in Medical Oncology (2018) Vol. 10
Open Access | Times Cited: 274
Genetic Markers in Triple-Negative Breast Cancer
Zuzana Sporikova, Vladimíra Koudeláková, Radek Trojanec, et al.
Clinical Breast Cancer (2018) Vol. 18, Iss. 5, pp. e841-e850
Open Access | Times Cited: 230
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
Xin Jin, Donglin Ding, Yuqian Yan, et al.
Molecular Cell (2018) Vol. 73, Iss. 1, pp. 22-35.e6
Open Access | Times Cited: 217
PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
Mohammad Ahmed Khan, Vineet Jain, Md. Rizwanullah, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 11, pp. 2181-2191
Closed Access | Times Cited: 203
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14360-14360
Open Access | Times Cited: 111
Deubiquitinases in cancer
Grant Dewson, Pieter J.A. Eichhorn, David Komander
Nature reviews. Cancer (2023) Vol. 23, Iss. 12, pp. 842-862
Closed Access | Times Cited: 110
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 297-313
Closed Access | Times Cited: 65
DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4
Xin Jin, Yuqian Yan, Dejie Wang, et al.
Molecular Cell (2018) Vol. 71, Iss. 4, pp. 592-605.e4
Open Access | Times Cited: 143
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, et al.
Cells (2019) Vol. 8, Iss. 4, pp. 321-321
Open Access | Times Cited: 129
Immunomodulation by anticancer cell cycle inhibitors
Giulia Petroni, Silvia C. Formenti, Selina Chen‐Kiang, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 669-679
Open Access | Times Cited: 118
CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Dinoop Ravindran Menon, Yuchun Luo, John J. Arcaroli, et al.
Cancer Research (2018) Vol. 78, Iss. 23, pp. 6561-6574
Open Access | Times Cited: 114
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
Angela Chou, Danielle Froio, Adnan Nagrial, et al.
Gut (2017) Vol. 67, Iss. 12, pp. 2142-2155
Open Access | Times Cited: 112
BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail
Zhong‐yi Qin, Tao Wang, Siyuan Su, et al.
Cancer Research (2019) Vol. 79, Iss. 19, pp. 4869-4881
Closed Access | Times Cited: 107
OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability
Honghong Zhou, Yongshuo Liu, Rui Zhu, et al.
Oncogene (2018) Vol. 37, Iss. 25, pp. 3356-3368
Closed Access | Times Cited: 88
TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1
Guillem Lambies, Martina Miceli, Catalina Martínez-Guillamon, et al.
Cancer Research (2018) Vol. 79, Iss. 1, pp. 33-46
Open Access | Times Cited: 88
The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
Tingting Zou, Zhenghong Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5754-5754
Open Access | Times Cited: 82
PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
Chunhua Chen, Shiheng Li, Junli Xue, et al.
JCI Insight (2021) Vol. 6, Iss. 8
Open Access | Times Cited: 60
BET proteins: Biological functions and therapeutic interventions
Jiawei Guo, Qingquan Zheng, Yong Peng
Pharmacology & Therapeutics (2023) Vol. 243, pp. 108354-108354
Closed Access | Times Cited: 40
Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions
Tangming Guan, Mei Li, Yan Song, et al.
Advanced Science (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 23
Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions
Smruthi Vijayaraghavan, Stacy Moulder, Khandan Keyomarsi, et al.
Targeted Oncology (2017) Vol. 13, Iss. 1, pp. 21-38
Closed Access | Times Cited: 84
USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization
Chenming Wu, Kuntian Luo, Fei Zhao, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 10, pp. 1855-1869
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top